Table of contents
- Manufacture, marketing and sale
- Consultation launched to ensure patients have a say in medicines regulation
- EU-US mutual recognition of pharmaceuticals now fully implemented
- Commission introduces new medical device manufacturer’s incident report
- World Health Organization sets out its priorities until 2023
- Data protection and confidential information
- Government releases principles for NHS data sharing
- Information Commissioner's Office seeks views on updated data sharing code of practice
- Brexit
- Exclusive English jurisdiction clauses—effective after a no deal Brexit? (Gulf International Bank BSC v Aldwood)
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
This week’s edition of Life Sciences highlights includes the news that the MHRA have launched a new consultation to optimise patient and public engagement in their work, the EU-US mutual recognition agreement for inspections of manufacturing sites has been fully implemented, the WHO’s new five-year plan and what it entails, and the new government principles on NHS data sharing.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial